kabutan

TOWA PHARMA, 3% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 10 yen

Thu May 15, 2025 3:30 pm JST Earnings

4553 TOWA PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

TOWA PHARMACEUTICAL CO.,LTD. <4553> [TSE Prime] announced its financial results after the market closed on May 15th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 increased 6.8% from the previous period to 26.1 billion yen. However, for the fiscal year ending March 2026, the consolidated ordinary profit is expected to decrease by 3.3% from the previous period to 25.3 billion yen.

At the same time, the company has decided to increase the dividend this fiscal year to 80 yen, an increase of 10 yen from the previous fiscal year.

In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit dropped to 4.39 billion yen, a 39.8% decrease compared to the same period last year. The operating profit margin worsened from 7.5% in the same period last year to 7.0%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 208,859 5,514 5,141 2,201 44.7 60 May 15, 2023 J-GAAP
Mar, 2024 227,934 17,647 24,477 16,173 328.6 60 May 14, 2024 J-GAAP
Mar, 2025 259,594 23,242 26,152 18,986 385.7 70 May 15, 2025 J-GAAP
YoY +13.9% +31.7% +6.8% +17.4% +17.4%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 259,500 23,200 26,100 18,900 384.0 70 May 7, 2025 J-GAAP
Mar, 2025 Results 259,594 23,242 26,152 18,986 385.7 70 May 15, 2025 J-GAAP
Revision Rate +0.0% +0.2% +0.2% +0.5% +0.5%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 123,404 10,513 10,338 6,555 133.2 30 Nov 12, 2024 J-GAAP
Apr - Sep, 2025 Guidance 134,500 12,000 11,100 8,000 162.5 40 May 15, 2025 J-GAAP
YoY +9.0% +14.1% +7.4% +22.0% +22.0%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 227,934 17,647 24,477 16,173 328.6 60 May 14, 2024 J-GAAP
Mar, 2025 259,594 23,242 26,152 18,986 385.7 70 May 15, 2025 J-GAAP
Mar, 2026 Guidance 280,000 27,000 25,300 17,700 359.6 80 May 15, 2025 J-GAAP
YoY +7.9% +16.2% -3.3% -6.8% -6.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 59,609 4,443 7,308 4,655 94.6 7.5 May 14, 2024 J-GAAP
Apr - Jun, 2024 62,566 5,672 8,593 5,495 111.6 9.1 Aug 8, 2024 J-GAAP
Jul - Sep, 2024 60,838 4,841 1,745 1,060 21.5 8.0 Nov 12, 2024 J-GAAP
Oct - Dec, 2024 70,333 8,098 11,418 8,069 163.9 11.5 Feb 13, 2025 J-GAAP
Jan - Mar, 2025 65,857 4,631 4,396 4,362 88.6 7.0 May 15, 2025 J-GAAP
YoY +10.5% +4.2% -39.8% -6.3% -6.3%

Related Articles